Search

Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’ are now open for applications. The bi-annual awards reflect the long-term commitment to promoting the health and well-being of farm animals.

Boehringer Ingelheim Academy

Find out more about our networking and educational initiative

Welcome to Innovation at Boehringer Ingelheim

Watch our video and find out more about innovation at Boehringer Ingelheim.

Boehringer Ingelheim Access to Healthcare Strategy 2025

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering more health to humans, animals and communities around the world. Read more about our holistic approach.

ArisGlobal acquires Boehringer Ingelheim technology

Boehringer Ingelheim’s signal analytics technology is acquired by ArisGlobal

Boehringer Ingelheim China for a green future

Boehringer Ingelheim China for a green future: China employees were collecting trash on Nanhui Zui Beach for a greener future

Boehringer Ingelheim announces appointments Board of Managing Directors

Boehringer Ingelheim collaborates with the Broad Institute

Boehringer Ingelheim and researchers at the Broad Institute of MIT and Harvard are collaborating to tackle the unmet needs of people living with mental health conditions.

Boehringer Ingelheim advances SIRP immune-oncology program

Boehringer and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371

Boehringer Ingelheim partners with PetMedix

Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim Academy Video 2023

Boehringer Ingelheim’s Academy initiative provides networking opportunities, education and facilitates conversations across the innovation community.

Boehringer receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim Innovation Prize Video 2023

Boehringer Ingelheim's Innovation Prize provides valuable resources to help early-stage companies progress their science.

Patient Safety & Pharmacovigilance at Boehringer Ingelheim

Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.

Boehringer unveils first global sustainability publication

Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’

Boehringer Ingelheim reaches more patients than ever, innovation drives growth

Boehringer Ingelheim reports a strong performance in 2022.

Boehringer Ingelheim Social Engagements

Boehringer Ingelheim Social Engagements Contributes to company commitment to impact 50 million people in vulnerable communities by 2030 through supporting social entrepreneurs and innovative solutions

Boehringer Ingelheim appointment to Board Managing Directors

Boehringer Ingelheim announces appointments to Board of Managing Directors

Boehringer biopharmaceuticals China receives approval supply EU and US

Boehringer Ingelheim Biopharmaceuticals China receives approval for supply of EU and US markets

Flood-disaster-in-Germany-donation-from-Boehringer-Ingelheim

Boehringer Ingelheim increases donation for emergency flood relief to EUR 1 million

Award: Boehringer Ingelheim is Global Top Employer 2022

Global Top Employer 2022

Boehringer Ingelheim announces appointments

Boehringer Ingelheim 2022 half year results

First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline

Boehringer Ingelheim strong growth pipeline acceleration 2023

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers